Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019045 (
hemoglobinopathies
)
2,704
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hemoglobinopathy
comprises a group of inherited
hemoglobin disorders
in which hemoglobin (Hb) was improperly formed, but the cause is not depletion of the globin gene. Typically, when the basic pathogenesis is a single
substitution disorder
, only one aberration presents in the secondary structure. However, the manifested or functional aberration resulting from the structural aberration usually varies. It is sometimes difficult to compare the degree of functional aberration among such
hemoglobin disorders
. A functional analysis was performed on 4 important beta
hemoglobinopathies
(hemoglobin C, D, E, and S) using PolyPhen, a novel bioinformatic tool. The mutations Hb C (beta 6, Glu --> Lys), Hb D (beta 121, Glu --> Gln), Hb E (beta 26, Glu --> Lys), and Hb S (beta 6, Glu --> Val) were selected for further study. According to the in silico mutation study, the functional change in the studied
hemoglobinopathies
was variable. The position-specific independent counts (PSIC) difference score ranged from 1.362 (Hb D) to 2.986 (Hb S). Regarding the degree of damage, all had probable damage. This analysis demonstrated that the functional aberration in the
hemoglobinopathy
was based on complex pathogenesis. Identifying only the structural aberration in a
hemoglobinopathy
is not sufficient; additional functional analysis is recommended. The functional analysis presented here may be a good model for further research.
...
PMID:Analysis of functional aberration of some important beta hemoglobinopathies (hemoglobin C, D, E, and S) from nanostructures. 1729 82